SK Bioscience Approved to Supply Improved Novavax COVID-19 Vaccine in Asia
Improved Novavax COVID-19 Vaccine Receives Urgent Approval from Ministry of Food and Drug Safety SK Bioscience, under the leadership of CEO Jae-yong Ahn, has received urgent approval from the Ministry of Food and Drug Safety for its improved unit cost vaccine, the Novavax COVID-19 Vaccine 2023-2024, designed to combat the omicron submutation (XBB.1.5) using synthetic […]
